Global private equity and venture capital news and research

Biotech sector suffers from PE investment slump, weakens for third monthp

15 Aug 2014

biotechPrivate equity and venture capital investment in the biotechnology sector has weakened for the third successive month due to a dearth of dealmaking, new research suggests.

Sorry, you have reached your quota of 1 free article a week or you are attempting to read a Premium story. To read more, simply sign-up to our daily newsletter.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015